Document is current
Any future updates will be listed below
-
Authors
Teng, Chengwen https://orcid.org/0000-0001-9239-2125
Frei, Christopher R. https://orcid.org/0000-0002-0692-4787
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR001120, UL1 TR002645)
- License Information
-
More Information
Article History
Accepted: 22 June 2021
First Online: 17 July 2021
Declarations
:
: No funding was sought for this research study. Dr. Frei was supported, in part, by a NIH Clinical and Translational Science Award (National Center for Advancing Translational Sciences, UL1 TR001120 and UL1 TR002645) while the study was being conducted. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: Dr. Frei’s institution has received grants for research from AstraZeneca Pharmaceuticals in the last 36 months.
: The Institutional Review Board (IRB) of The University of South Carolina determined that this study is not human subjects research (IRB number: Pro00101342).
: Not applicable.
: Not applicable.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
: Codes used during the current study are available from the corresponding author on reasonable request.
: Study concept and design: all authors. Statistical analysis: CT. Interpretation of data: all authors. Drafting of the manuscript: CT. Critical revision of the manuscript for important intellectual content: all authors. Study supervision: CT.
